ALPS Advisors’s CRISPR Therapeutics CRSP Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-42,581
Closed -$2.78M 1038
2022
Q3
$2.78M Sell
42,581
-3,369
-7% -$220K 0.03% 243
2022
Q2
$2.79M Buy
+45,950
New +$2.79M 0.03% 251
2019
Q2
Sell
-125,116
Closed -$4.47M 885
2019
Q1
$4.47M Buy
125,116
+6,326
+5% +$226K 0.03% 177
2018
Q4
$3.39M Buy
+118,790
New +$3.39M 0.03% 184